{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:10:30Z","timestamp":1788588630398,"version":"build-2803163510"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1093\/jac\/dkq237","type":"journal-article","created":{"date-parts":[[2010,6,30]],"date-time":"2010-06-30T01:10:05Z","timestamp":1277860205000},"page":"1862-1877","source":"Crossref","is-referenced-by-count":122,"title":["Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"65","author":[{"given":"Matthew E.","family":"Falagas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evridiki K.","family":"Vouloumanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios G.","family":"Togias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Karadima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios M.","family":"Kapaskelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros I.","family":"Rafailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,6,29]]},"reference":[{"key":"key\n\t\t\t\t20170425164501_DKQ237C1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","article-title":"Urinary tract infection: self-reported incidence and associated costs","volume":"10","author":"Foxman","year":"2000","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C2","first-page":"2728","article-title":"Natural history of urinary tract infection in a primary care environment in Canada","volume":"12","author":"Nickel","year":"2005","journal-title":"Can J Urol"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jac\/34.6.853","article-title":"Fosfomycin trometamol","volume":"34","author":"Reeves","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0891-5520(03)00006-0","article-title":"Emerging antibiotic resistance in urinary tract pathogens","volume":"17","author":"Gupta","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jinf.2008.07.004","article-title":"Resistance to fluoroquinolones and treatment failure\/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli","volume":"57","author":"Gagliotti","year":"2008","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.diagmicrobio.2007.06.012","article-title":"Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes","volume":"59","author":"Ho","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C7","first-page":"172","article-title":"Addressing the challenge of extended-spectrum \u03b2-lactamases","volume":"10","author":"Zahar","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/00003495-199753040-00007","article-title":"Fosfomycin tromethamine: a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections","volume":"53","author":"Patel","year":"1997","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijantimicag.2009.08.013","article-title":"Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections","volume":"34","author":"Roussos","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/527442","article-title":"Fosfomycin: use beyond urinary tract and gastrointestinal infections","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10096-007-0456-4","article-title":"Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin","volume":"27","author":"Falagas","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijantimicag.2009.03.009","article-title":"Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies","volume":"34","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/13543780902967624","article-title":"Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies","volume":"18","author":"Falagas","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/427507","article-title":"Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults","volume":"40","author":"Nicolle","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C16","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/clind\/15.Supplement_1.S216","article-title":"Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration","volume":"15","author":"Rubin","year":"1992","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S0266462300009570","article-title":"Assessing the quality of randomized controlled trials. Current issues and future directions","volume":"12","author":"Moher","year":"1996","journal-title":"Int J Technol Assess Health Care"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C19","first-page":"360","article-title":"Comparison efficacy of single dose fosfomycin with ciprofloxacin in the treatment of urinary tract infection in symptomatic women","volume":"34","author":"Bozkurt","year":"2008","journal-title":"Turk Uroloji Dergisi"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dki169","article-title":"Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis","volume":"56","author":"Gupta","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C21","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0149-2918(00)86734-X","article-title":"Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection","volume":"21","author":"Stein","year":"1999","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0924-8579(98)00021-1","article-title":"A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women","volume":"10","author":"Minassian","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0399-077X(05)80760-7","article-title":"Le traitement monodose de la cystite non compliquee chez la femme propos d'un essai fosfomycine trometamol (Monuril\u00ae) versus pefloxacine","volume":"25","author":"Richaud","year":"1995","journal-title":"Med Mal Infect"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C24","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/AAC.38.11.2612","article-title":"Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women","volume":"38","author":"Elhanan","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01871127","article-title":"Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women","volume":"15","author":"Van Pienbroek","year":"1993","journal-title":"Pharm World Sci"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C26","first-page":"1007","article-title":"Single oral dose of phosphomycin trometamol versus pipemidic acid and norfloxacin in treating uncomplicated low-level urinary tract infections","volume":"10","author":"Cortes","year":"1992","journal-title":"Aten Primaria"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000282164","article-title":"Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections","volume":"46","author":"de Jong","year":"1991","journal-title":"Urol Int"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170425164501_DKQ237C28","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1007\/BF01643433","article-title":"Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice","volume":"18","author":"Boerema","year":"1990","journal-title":"Infection"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000238815","article-title":"Single-dose fosfomycin trometamol versus multiple-dose cotrimoxazole in the treatment of lower urinary tract infections in general practice. Multicenter Group of General Practitioners","volume":"36","author":"Crocchiolo","year":"1990","journal-title":"Chemotherapy"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000238814","article-title":"A comparative double-blind randomised study of single dose fosfomycin trometamol with trimethoprim in the treatment of urinary tract infections in general practice","volume":"36","author":"Harvard Davis","year":"1990","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170425164501_DKQ237C31","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1007\/BF01643431","article-title":"Fosfomycin trometamol versus ofloxacin\/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study","volume":"18","author":"Naber","year":"1990","journal-title":"Infection"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000238810","article-title":"Fosfomycin trometamol versus amoxycillin\u2014single-dose multicenter study of urinary tract infections","volume":"36","author":"Neu","year":"1990","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170425164501_DKQ237C33","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/BF01643432","article-title":"Single dose fosfomycin trometamol versus multiple dose norfloxacin over three days for uncomplicated UTI in general practice","volume":"18","author":"Reynaert","year":"1990","journal-title":"Infection"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000238813","article-title":"Fosfomycin trometamol (Monuril) versus norfloxacin in single dose for adult female uncomplicated UTIs: multicenter randomized, double-blind study","volume":"36","author":"Selvaggi","year":"1990","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C35","first-page":"55","article-title":"Effect and pharmacokinetics of netilmicin given as bolus intramuscular administration: an open comparative trial versus amikacin and fosfomycin in elderly patients affected by urinary tract infections","volume":"11","author":"Caramalli","year":"1991","journal-title":"Int J Clin Pharmacol Res"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF01641417","article-title":"Single dose and conventional treatment for acute bacterial and non-bacterial dysuria and frequency in general practice","volume":"18","author":"Cooper","year":"1990","journal-title":"Infection"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000238817","article-title":"Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections of the elderly","volume":"36","author":"Ferraro","year":"1990","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C38","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10096-009-0805-6","article-title":"Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy","volume":"28","author":"Estebanez","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00192-006-0190-y","article-title":"Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy?","volume":"18","author":"Bayrak","year":"2007","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0924-8579(00)00351-4","article-title":"Treatment of lower urinary tract infection in pregnancy","volume":"17","author":"Krcmery","year":"2001","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000238818","article-title":"Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria in pregnancy","volume":"36","author":"Zinner","year":"1990","journal-title":"Chemotherapy"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170425164501_DKQ237C42","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1007\/BF01643435","article-title":"Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results","volume":"18","author":"Thoumsin","year":"1990","journal-title":"Infection"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000238816","article-title":"Fosfomycin trometamol versus netilmicin in children's lower urinary tract infections","volume":"36","author":"Principi","year":"1990","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C44","first-page":"290","article-title":"Treatment of lower urinary tract infections in children: single dose fosfomycin trometamol versus pipemidic acid","volume":"6","author":"Careddu","year":"1987","journal-title":"Chemioterapia"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000472876","article-title":"Trometamol salt of fosfomycin versus netilmicin: randomized multicenter study in children's lower urinary tract infections","volume":"13","author":"Varese","year":"1987","journal-title":"Eur Urol"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C46","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/AAC.39.5.1038","article-title":"Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm","volume":"39","author":"Kumon","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10156-007-0534-7","article-title":"Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model","volume":"13","author":"Mikuniya","year":"2007","journal-title":"J Infect Chemother"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170425164501_DKQ237C48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0924-8579(03)00232-2","article-title":"Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms","volume":"22","author":"Marchese","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C49","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.clinthera.2008.11.002","article-title":"Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland","volume":"30","author":"Borsari","year":"2008","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C50","first-page":"576","article-title":"Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery\/low birth weight","volume":"73","author":"Romero","year":"1989","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1542\/peds.2008-2583","article-title":"Urinary tract infections in 1- to 3-month-old infants: ambulatory treatment with intravenous antibiotics","volume":"124","author":"Dore-Bergeron","year":"2009","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C52","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1128\/AAC.00721-09","article-title":"Susceptibility of urinary tract bacteria to fosfomycin","volume":"53","author":"Maraki","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170425164501_DKQ237C53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C54","unstructured":"http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/050717s005lbl.pdf"},{"key":"key\n\t\t\t\t20170425164501_DKQ237C55","first-page":"77","article-title":"Analysis of oral fosfomycin calcium (Fosmicin) side-effects after marketing","volume":"31","author":"Mayama","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/65\/9\/1862\/13760187\/dkq237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:10:47Z","timestamp":1559229047000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkq237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,29]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,6,29]]},"published-print":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkq237","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6,29]]}}}